Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1448821366
总结
CYP2D6 poor metabolizer is not associated with likelihood of Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 normal metabolizer.